KLRK1 and neoplasm: Tumor cells, via EVs, secrete NKG2D ligands such as MHC class I chain-related proteins (MICA and B) or UL-16 binding proteins (ULBP) that upon interaction with NKG2D receptors on NK-cells surface determine their downregulation resulting in a general dysfunction of NK-cells [43].